Results 21 to 30 of about 238,371 (341)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure

Clinical Cardiology, 2022
Red blood cell distribution width (RDW) and N‐terminal pro brain natriuretic peptide (NT‐proBNP) may predict the prognosis of heart failure (HF). However, the impact of combined RDW and NT‐proBNP levels as a prognostic marker of HF remains unclear and ...
L. Liang, Liyan Huang, Xue-yan Zhao, Lang Zhao, P. Tian, B. Huang, Jiayu Feng, Jian Zhang, Yuhui Zhang   +8 more
semanticscholar   +1 more source

Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.

Journal of the American College of Cardiology, 2021
BACKGROUND Although intensive blood pressure reduction has cardiovascular benefits, the absolute benefit is greater in those at higher cardiovascular disease (CVD) risk.
Aliza Hussain, Wensheng Sun, A. Deswal, J. D. de Lemos, J. McEvoy, R. Hoogeveen, K. Matsushita, D. Aguilar, B. Bozkurt, S. Virani, A. Shah, E. Selvin, Chiadi Ndumule, C. Ballantyne, Vijay Nambi   +14 more
semanticscholar   +1 more source

A novel electrochemical strategy for NT-proBNP detection using IMFET for monitoring heart failure by saliva analysis.

Talanta: The International Journal of Pure and Applied Analytical Chemistry, 2022
Heart failure (HF) is a chronic cardiovascular disease that represents main cause of mortality worldwide, particularly for elderly. N-terminal pro-brain natriuretic peptide (NT-proBNP) was identified as the gold standard biomarker for HF diagnosis and ...
Hamdi Ben Halima, F. Bellagambi, Marie Hangouët, A. Alcacer, N. Pfeiffer, Albert Heuberger, N. Zine, J. Bausells, A. Elaissari, A. Errachid   +9 more
semanticscholar   +1 more source

Prognostic value of NT-proBNP in patients with severe COVID-19

Respiratory Research, 2020
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern.
Lei Gao, D. Jiang, X. Wen, Xiao-cheng Cheng, Min Sun, B. He, Lin-na You, P. Lei, Xiao-wei Tan, S. Qin, Guoqiang Cai, Dongyin Zhang   +11 more
semanticscholar   +1 more source

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study

Respiratory Research, 2018
Background While the N-terminal pro-brain-type natriuretic peptide (NT-proBNP) at rest is known to be associated with prognosis in pulmonary arterial hypertension (PAH), it is unclear if the NT-proBNP response to exercise (ΔNT-proBNP) can contribute to a
J. Kutsch, C. Faul, W. von Scheidt, M. Schwaiblmair, T. M. Berghaus   +4 more
doaj   +1 more source

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [PDF]

, 2015
We assessed the predictive ability of selected biomarkers using N-terminal pro-brain natriuretic peptide (NT-proBNP) as the benchmark and tried to establish a multi-biomarker approach to heart failure (HF) in hypertensive patients. In 120 hypertensive
Agata Bielecka-Dabrowa, Anna Gluba-Brzózka, Campeau, Jacek Rysz, Li, Maciej Banach, Marta Michalska-Kasiczak, Małgorzata Misztal, McCullough, Ravassa, Wei   +10 more
core   +2 more sources

A Multi-marker Model for Predicting Decompensated Heart Failure in Patients with Prior Acute Myocardial Infarction [PDF]

, 2020
The aim of the study was to assess the prognostic value of determining the plasma concentration of NT-proBNP and ST2 in the patients with decompensated HF and prior acute myocardial infarction and their combination in this category of patients.Materials ...
Levandovska, K. (Khrystyna)
core   +3 more sources

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials

ESC Heart Failure, 2021
Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are both associated with increased levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). It is known that AF impairs the diagnostic accuracy of NT‐proBNP for HF. The aim of
S. M. Werhahn, C. Becker, M. Mende, H. Haarmann, Kathleen Nolte, U. Laufs, S. Zeynalova, M. Löffler, N. Dagres, D. Husser, M. Dörr, S. Gross, S. Felix, A. Petersmann, C. Herrmann-Lingen, L. Binder, M. Scherer, G. Hasenfuss, B. Pieske, F. Edelmann, R. Wachter   +20 more
semanticscholar   +1 more source

Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH [PDF]

, 2015
Aim Traditionally, risk stratification in heart failure (HF) emphasizes assessment of high risk. We aimed to determine if biomarkers could identify patients with HF at low risk for death or HF rehospitalization.
Anand, Behnes, Boer, Boer, Boer, Boer, Chen, Cheng, Christenson, De Boer, DeLong, Edelmann, Fonarow, Fonarow, Gheorghiade, Grafft, Jaarsma, Jaarsma, Jencks, Kimmenade, Levy, Lok, Maisel, Marti, Masson, Meijers, Meijers, Motiwala, O'Brien, O'Connor, Ouwerkerk, Peacock, Pencina, Phillips, Postmus, Rahimi, Ruifrok, Salah, Setoguchi, Sharma, Stewart, Troughton, Vazquez, Velde, Veldhuisen, Yancy, Yu   +46 more
core   +1 more source

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction

ESC Heart Failure, 2022
Aims The N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a commonly used biomarker in heart failure for diagnosis and prognostication. We aimed to determine the prevalence of NT‐proBNP testing, distribution of NT‐proBNP concentrations, and ...
James L. Januzzi, Xi Tan, Lingfeng Yang, Joanne E. Brady, Mei Yang, Puja Banka, Dominik Lautsch   +6 more
doaj   +1 more source